Evidence map›Paper›PMID 27988968›Full record

SynthesisEpilepsia2017

Premature mortality of epilepsy in low- and middle-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.

Francis Levira, David J Thurman, Josemir W Sander, W Allen Hauser, Dale C Hesdorffer, Honorati Masanja, Peter Odermatt, Giancarlo Logroscino, Charles R Newton, Epidemiology Commission of the International League Against Epilepsy

Abstract readSystematic Review
In one paragraph

Synthesis in Epilepsia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Antiseizure Medications and Bone Health.Neurology and therapy · 2025
    Review
  15. Observational
  16. Article
  17. Epilepsy in low- to middle-income countries.Current opinion in neurology · 2025
    Review
  18. Article
  19. Review
  20. Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francis LeviraIfakara Health Institute, Dar-es-Salaam, Tanzania.
David J ThurmanDepartment of Neurology, Emory University, Atlanta, Georgia, U.S.A.
Josemir W SanderNIHR University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, United Kingdom.
W Allen HauserSergievsky Center, Columbia University Medical Center, New York, New York, U.S.A.
Dale C HesdorfferSergievsky Center, Columbia University Medical Center, New York, New York, U.S.A.
Honorati MasanjaIfakara Health Institute, Dar-es-Salaam, Tanzania.
Peter OdermattSwiss Tropical and Public Health Institute, Basel, Switzerland.
Giancarlo LogroscinoUniversity of di Bari Aldo Moro, Bari, Italy.
Charles R NewtonDepartment of Neurosciences, Institute of Child Health, University College London, London, United Kingdom.
Epidemiology Commission of the International League Against Epilepsy

Funding

Wellcome Trust 203077
6 · The paper itself

Abstract

To determine the magnitude of risk factors and causes of premature mortality associated with epilepsy in low- and middle-income countries (LMICs). We conducted a systematic search of the literature reporting mortality and epilepsy in the World Bank-defined LMICs. We assessed the quality of the studies based on representativeness; ascertainment of cases, diagnosis, and mortality; and extracted data on standardized mortality ratios (SMRs) and mortality rates in people with epilepsy. We examined risk factors and causes of death. The annual mortality rate was estimated at 19.8 (range 9.7-45.1) deaths per 1,000 people with epilepsy with a weighted median SMR of 2.6 (range 1.3-7.2) among higher-quality population-based studies. Clinical cohort studies yielded 7.1 (range 1.6-25.1) deaths per 1,000 people. The weighted median SMRs were 5.0 in male and 4.5 in female patients; relatively higher SMRs within studies were measured in children and adolescents, those with symptomatic epilepsies, and those reporting less adherence to treatment. The main causes of death in people with epilepsy living in LMICs include those directly attributable to epilepsy, which yield a mean proportional mortality ratio (PMR) of 27.3% (range 5-75.5%) derived from population-based studies. These direct causes comprise status epilepticus, with reported PMRs ranging from 5 to 56.6%, and sudden unexpected death in epilepsy (SUDEP), with reported PMRs ranging from 1 to 18.9%. Important causes of mortality indirectly related to epilepsy include drowning, head injury, and burns. Epilepsy in LMICs has a significantly greater premature mortality, as in high-income countries, but in LMICs the excess mortality is more likely to be associated with causes attributable to lack of access to medical facilities such as status epilepticus, and preventable causes such as drowning, head injuries, and burns. This excess premature mortality could be substantially reduced with education about the risk of death and improved access to treatments, including AEDs.

Indexed as

Mortality, PrematureAdolescentAge FactorsChildDatabases, BibliographicDeath, SuddenDeveloping CountriesEpilepsyFemaleHumansMaleRisk FactorsSex FactorsSocioeconomic FactorsCase fatalityConvulsionsDeathDeveloping countriesPremature mortalityResource-poor countriesSeizures

Identifiers

PMID27988968
PMCPMC7012644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.